Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepagina
  2. Aandelen
  3. Nederland
  4. Euronext Amsterdam
  5. Pharming Group N.V.
  6. Nieuws
  7. Andere talen
    PHARM   NL0010391025

PHARMING GROUP N.V.

(PHARM)
  Rapport
Real Time Euronext Amsterdam  -  16:25:26 27-01-2023
1.303 EUR   +1.80%
25/01ASML kleine stijger in rode AEX
AM
25/01Cijfers ASML overtuigen niet op rode beurs
AM
24/01AEX neemt gas terug
AM
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Nieuws in andere talen op PHARMING GROUP N.V.
18/01Pharming N : Bank of America Corporation - Pharming Group N.V. - Leiden
17/01Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden
12/01Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden
2022Pharming announces positive interim analysis data from open-label extension study of le..
2022Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden
2022Pharming announces positive interim analysis data from open-label extension study of le..
2022Pharming Group N.V. Announces Positive Interim Analysis Data from Open-Label Extension ..
2022Pharming announces publication of data from Phase 3 Study of leniolisib in patients wit..
2022Pharming Group N.V. Announces Positive Results of Phase 3 Clinical Trial of Investigati..
2022Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden
2022Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden
2022Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden
2022Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden
2022Pharming Group Says European Medicines Agency Validates Marketing Authorization Applica..
2022Pharming Group N.V. Announces European Medicines Agency Validates its Marketing Authori..
2022Pharming N : Q3 2022 Financial Results Presentation
2022Pharming Group N.V. Reports Earnings Results for the Nine Months Ended September 30, 20..
2022Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden
2022Pharming Group Seeks European Approval of Treatment for Rare Primary Immunodeficiency
2022Pharming Group N.V. Submits Marketing Authorisation Application to European Medicines A..
2022Sector Update: Health Care Stocks Rally Premarket Wednesday
2022Pharming Group Says Application for Primary Immunodeficiency Drug Accepted for Priority..
2022Pharming Group N.V. Announces US FDA Acceptance for Priority Review of its New Drug App..
2022Pharming N : Halfjaarlijkse financiële verslaggeving
2022Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden
2022Pharming N : BlackRock Inc. - Pharming Group N.V. - Leiden
2022Point sur les fortes variations du jour : Marie Bri..
2022Pharming N : Group reports financial results for the first half of 2022
2022Pharming Group N.V. Reports Earnings Results for the Half Year Ended June 30, 2022
2022Pharming Group N.V. Announces Resignation of Robert Friesen, Chief Scientific Officer a..
2022Pharming N : H1 2022 Financial Results Presentation
2022Pharming Announces New ICD-10-CM Code for APDS, a Rare Primary Immunodeficiency
2022Pharming Group N.V. Receives Accelerated Assessment in Europe for Leniolisib for the Tr..
2022Pharming N : Group to present at Jefferies Healthcare Conference 2022
2022GIMV NV completed the acquisition of 20.87% stake in Bioconnection B.V. from Pharming G..
2022Pharming Group's Immunodeficiency Disease Drug Receives 'Promising Innovative Medicine'..
2022Pharming Receives Agreement of Paediatric Investigation Plan and Promising Innovative M..
2022Gimv Invests In Contract Development Group BioConnection
2022GIMV NV reached an agreement to acquire 20.87% stake in Bioconnection B.V. from Pharmin..
2022Pharming Reports Data on Leniolisib Trial to Treat Rare Immunodeficiency
2022Pharming Group N.V. Announces Positive Data from Phase II/III Leniolisib Trial Presente..
2022Pharming Group N.V. Reports Earnings Results for the Full Year Ended December 31, 2021
2022Pharming N : Group Notice of 2021 Full Year Results
2022Pharming Group N.V. Announces Positive Results of Phase II/III Pivotal Clinical Study o..
2022Pharming Receives Positive European Medicines Agency Decision on Paediatric Investigati..
2022Pharming Group and Sanofi Renew Strategic Manufacturing Partnership Agreement
2021Sanofi : partnenariat renouvelé avec le néerlandais Pharming
2021Pharming Group, Sanofi Renew Strategic Manufacturing Partnership Agreement
2021Pharming Group and Sanofi Renew Strategic Manufacturing Partnership Agreement
2021Pharming Group reports financial results for the first nine months of 2021
2021Pharming Group N.V. Provides Earnings Guidance for the Year 2021
2021Pharming N : Pharming Group Notice of 9M Results
2021Pharming N : Group Notice of 9M Results
2021JPMorgan opens South Korea commercial banking office in international expansion
2021Pharming N : Pharming announces results from clinical trials for the treatment of COVID-19..
2021Pharming N : announces results from clinical trials for the treatment of COVID-19 with RUC..
2021Pharming Announces Results from Clinical Trials for the Treatment of COVID-19 with RUCO..
2021Pharming to Seek Acquisitions
2021Pharming N : Group reports financial results for the first half of 2021
2021Sign Up Now : Pharming's Half Year Financial Results Webinar
2021Pharming N : signs agreement with NewBridge Pharmaceuticals for the commercialization of R..
2021Pharming Signs Agreement with Newbridge Pharmaceuticals for the Commercialization of Ru..
2021Orchard Therapeutics : to Collaborate With Pharming Group on Treatm..
2021Pharming N : Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and..
2021Orchard Therapeutics : and Pharming Group Announce Collaboration to Develop and Commercial..
2021Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercia..
2021Orchard Therapeutics plc announced that it expects to receive $7.5 million in funding f..
2021Pharming N : Pharming announces completion of enrolment in Phase II/III study with lenioli..
2021Pharming N : announces completion of enrolment in Phase II/III study with leniolisib for a..
2021Pharming Group N.V Announces Completion of Enrolment in Phase II/III Study with Lenioli..
2021Pharming Group N.V.(ENXTAM:PHARM) added to Netherlands ASCX A..
2021Pharming N : appoints Anurag Relan as Chief Medical Officer and Robert Friesen as Chief Sc..
2021Pharming Group N.V. Announces Executive Changes
2021Pharming Group N.V.(ENXTAM:PHARM) dropped from AMX Index
2021Pharming N : announces the reimbursement of RUCONESTģ in Spain
2021Pharming N : Group to present at Jefferies Virtual Healthcare Conference
2021Pharming Group N.V. Announces Executive Changes
2021Pharming Group N.V. Reports Earnings Results for the First Quarter Ended March 31, 2021
2021Pharming N : Group reports financial results for the first quarter of 2021
2021Pharming Group N.V. : des résultats sans saveur
2021Pharming Group N.V Announces Enrolment of First Patient in Multicentre Phase IIb Clinic..
2021Pharming Group N.V. Announces Board Changes
2021Pharming N : Phishing, Pharming, Malware, And Other Internet Delights
2021Pharming Group Seeks Acquisitions
2021Pharming Group N.V. Reports Earnings Results for the Full Year Ended December 31, 2020
2021Pharming Group N.V. Provides Earnings Guidance for the Remainder of 2021
2021Pharming N : Group, in collaboration with Invitae Corporation, launches genetic testing pr..
2021Pharming Group N.V. in Collaboration with Invitae Corporation, Launches Genetic Testing..
2020Pharming Group N.V.(NasdaqGM:PHAR) added to NASDAQ Composit..
2020Pharming N : Group announces ADSs admitted to trade on Nasdaq under the symbol “PHAR..
2020Pharming N : Announces Instructions for Exchanging Listed Ordinary Shares into Nasdaq List..
2020Pharming N : Reports on Extraordinary General Meeting of Shareholders
2020Pharming Group N.V. Announces Board Appointments
2020Pharming N : announces enrolment of first patient in US clinical trial for the treatment o..
2020Pharming Group N.V. Announces Enrolment of First Patient in US Clinical Trial for the T..
2020Pharming N : Juergen Ernst to retire from Pharming's Board of Supervisory Directors after ..
2020Pharming Group N.V. Announces Management Changes
2020Pharming N : announces commitment to build a new downstream manufacturing facility for RUC..
2020Pharming Group N.V. Announces Commitment to Build A New Downstream Manufacturing Facili..
2020Pharming N : appoints Jeroen Wakkerman as Chief Financial Officer
Volgende evenement op PHARMING GROUP N.V.